PL3618826T3 - Kompozycje do leczenia zakażeń patogenami - Google Patents

Kompozycje do leczenia zakażeń patogenami

Info

Publication number
PL3618826T3
PL3618826T3 PL18723791.2T PL18723791T PL3618826T3 PL 3618826 T3 PL3618826 T3 PL 3618826T3 PL 18723791 T PL18723791 T PL 18723791T PL 3618826 T3 PL3618826 T3 PL 3618826T3
Authority
PL
Poland
Prior art keywords
compositions
treatment
pathogenic infections
pathogenic
infections
Prior art date
Application number
PL18723791.2T
Other languages
English (en)
Inventor
Walter SCHAUB
Original Assignee
Walter SCHAUB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter SCHAUB filed Critical Walter SCHAUB
Publication of PL3618826T3 publication Critical patent/PL3618826T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
PL18723791.2T 2017-05-04 2018-05-04 Kompozycje do leczenia zakażeń patogenami PL3618826T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH5992017 2017-05-04
PCT/EP2018/061607 WO2018202897A1 (en) 2017-05-04 2018-05-04 Compositions and treatment procedures for the treatment of pathogenic infections

Publications (1)

Publication Number Publication Date
PL3618826T3 true PL3618826T3 (pl) 2024-07-29

Family

ID=62148353

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18723791.2T PL3618826T3 (pl) 2017-05-04 2018-05-04 Kompozycje do leczenia zakażeń patogenami

Country Status (10)

Country Link
US (1) US12178916B2 (pl)
EP (1) EP3618826B1 (pl)
JP (1) JP7299876B2 (pl)
CN (1) CN110996941A (pl)
AU (1) AU2018263059B9 (pl)
CA (1) CA3062394A1 (pl)
HU (1) HUE067197T2 (pl)
PL (1) PL3618826T3 (pl)
WO (1) WO2018202897A1 (pl)
ZA (1) ZA201907487B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4178360A1 (en) * 2020-07-07 2023-05-17 WIAB Water Innovation AB Compositions and methods to disinfect, treat and prevent microbial infections
CN112811758B (zh) * 2020-12-31 2022-05-31 山西大学 一种秸秆碳复合材料及其制备方法和应用
CN112667922B (zh) * 2021-01-12 2022-06-28 山东大学 基于协同过滤的新型冠状病毒中药组方推荐方法及系统
CN115068500A (zh) * 2022-06-20 2022-09-20 张海杰 一种治疗幽门螺杆菌的药物
US12611425B2 (en) * 2022-10-10 2026-04-28 Wiab Water Innovation Ab Compositions and methods for treatment and prevention of pathogens

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB608069A (en) * 1945-03-16 1948-09-09 Mathieson Alkali Works Improvements in chlorine-dioxide-producing compositions
US4689169A (en) * 1983-11-10 1987-08-25 Rio Linda Chemical Company, Inc. Dry compositions for the production of chlorine dioxide
AU2623188A (en) * 1987-10-13 1989-05-02 New Generation Products, Inc. Chlorine dioxide germicidal composition
ATE128027T1 (de) * 1991-07-01 1995-10-15 Gergely Gerhard Lutsch- oder kautablette.
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US6099861A (en) * 1995-10-06 2000-08-08 Chemlink Laboratories, Llc Disinfectant effervescent tablet formulation
US5817337A (en) 1995-10-06 1998-10-06 Desenna; Richard A. Disinfectant effervescent tablet formulation
US6165505A (en) * 1995-10-06 2000-12-26 Chem-Link Laboratories, Llc Sterilant effervescent formulation
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US6605304B1 (en) 1998-02-09 2003-08-12 Bernard Technologies, Inc. Silicate-containing powders providing controlled, sustained gas release
US6846478B1 (en) * 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US6251372B1 (en) * 1998-02-27 2001-06-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6077502A (en) 1998-02-27 2000-06-20 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6592907B2 (en) 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
KR20060109915A (ko) * 2003-11-19 2006-10-23 벡타 리미티드 엔도퍼옥사이드 브리지 함유 화합물을 이용하여 헬리코박터파일로리 연관 질병의 치료를 위한 방법 및 조성물
EP1634948A1 (en) * 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
US20070172412A1 (en) * 2006-01-26 2007-07-26 Linda Hratko Thickened fluid composition comprising chlorine dioxide
JP2007217239A (ja) 2006-02-17 2007-08-30 Taiko Pharmaceutical Co Ltd 二酸化塩素発生組成物
CN101228868B (zh) * 2008-02-27 2010-06-09 河北科技大学 一元固体二氧化氯泡腾片及其制备方法
US20100209332A1 (en) 2009-02-19 2010-08-19 Basf Catalysts Llc Nonaqueous Chlorine Dioxide-Generating Compositions and Methods Related Thereto
JP2011037814A (ja) * 2009-08-14 2011-02-24 Synstar Japan Co Ltd マラリア原虫疾患予防又は治療用の５−ヘテロ環置換イミノ−９−ジアルキルアミノベンゾ［ａ］フェノキサチン化合物又はその塩とアーテミシニン誘導体との組み合わせ
CN101933938A (zh) * 2010-08-27 2011-01-05 王锡麟 一种缓释性体内病原体杀灭剂及其制备和使用方法
JP6242191B2 (ja) 2013-11-28 2017-12-06 一般財団法人 東京薬科大学付属社会医療研究所 可視光領域応答触媒体とこれを利用した水の分解する方法
JP6176530B2 (ja) 2013-11-29 2017-08-09 株式会社大阪ソーダ 汚物・嘔吐物処理用キット
WO2016196440A1 (en) * 2015-06-01 2016-12-08 Xeno Biosciences Inc. Methods and compositions to modulate the gut microbiota and to manage weight

Also Published As

Publication number Publication date
JP7299876B2 (ja) 2023-06-28
CN110996941A (zh) 2020-04-10
EP3618826C0 (en) 2024-02-21
ZA201907487B (en) 2023-04-26
EP3618826B1 (en) 2024-02-21
AU2018263059B9 (en) 2024-10-03
WO2018202897A1 (en) 2018-11-08
US20210259974A1 (en) 2021-08-26
CA3062394A1 (en) 2018-11-08
JP2020519683A (ja) 2020-07-02
AU2018263059A1 (en) 2019-12-12
HUE067197T2 (hu) 2024-10-28
US12178916B2 (en) 2024-12-31
AU2018263059B2 (en) 2024-09-19
EP3618826A1 (en) 2020-03-11

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
IL275482A (en) Asketamine for the treatment of depression
EP3448874A4 (en) COMPOSITIONS FOR TREATING A DISEASE
PL3785733T3 (pl) Kompozycja farmaceutyczna do leczenia autyzmu
IL262348A (en) Preparations for the treatment of excessive radiation disorders
ZA201907487B (en) Compositions and treatment procedures for the treatment of pathogenic infections
HUE061444T2 (hu) Készítmények a magas vérnyomás kezelésére
IL249640A0 (en) Preparations for the treatment of nosebleeds
HUE064253T2 (hu) Emulziók hüvelyi fertõzések kezelésére
IL275796A (en) Bacteriophage preparations for the treatment of Pseudomonas infection
ZA201604687B (en) Combination product for the prevention of sexually transmitted infections
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
EP3426671A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
IL271236A (en) Licofligozin for the treatment of non-alcoholic steatohepatitis
PL3823655T3 (pl) Kompozycje do leczenia wulwodynii
IL268166A (en) Fortified antimicrobial compound for antimicrobial treatment for biofilms
IL327077A (en) Varsedanib combinations for the treatment of glioma
IT201700085409A1 (it) Composizione per il trattamento di infezioni causate da agenti patogeni
SG11201707561RA (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
ZA201901948B (en) Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections
IL267059A (en) A preparation for the treatment of osteoarthritis
SMT202400184T1 (it) Composizioni per il trattamento di infezioni patogene
IL263336A (en) Compounds for the treatment of symphysiolysis
EP3511408A4 (en) COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIONS
ZA201705781B (en) Pharmaceutical compositions for the treatment of bacterial infections